FibroGen, Inc. (FGEN) At $53.55 Forms Top; Last Week The Sherwin-Williams Company (SHW) Coverage

Among 28 analysts covering Sherwin-Williams Company (NYSE:SHW), 21 have Buy rating, 0 Sell and 7 Hold. Therefore 75% are positive. Sherwin-Williams Company had 64 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Buy” on Sunday, January 28. The firm earned “Sector Weight” rating on Monday, March 21 by KeyBanc Capital Markets. The rating was maintained by Wells Fargo with “Market Perform” on Wednesday, October 25. The firm earned “Buy” rating on Thursday, July 13 by RBC Capital Markets. The stock of The Sherwin-Williams Company (NYSE:SHW) has “Buy” rating given on Friday, July 22 by CLSA. RBC Capital Markets maintained The Sherwin-Williams Company (NYSE:SHW) rating on Friday, January 29. RBC Capital Markets has “Outperform” rating and $315 target. The company was downgraded on Monday, July 11 by Seaport Global. KeyBanc Capital Markets maintained The Sherwin-Williams Company (NYSE:SHW) on Friday, September 1 with “Buy” rating. Citigroup initiated the shares of SHW in report on Friday, June 23 with “Buy” rating. The stock of The Sherwin-Williams Company (NYSE:SHW) earned “Overweight” rating by KeyBanc Capital Markets on Tuesday, April 4. See The Sherwin-Williams Company (NYSE:SHW) latest ratings:

12/02/2018 Broker: Susquehanna Rating: Buy New Target: $483.0 Maintain
02/02/2018 Broker: Seaport Global Rating: Buy New Target: $465.0 Upgrade
28/01/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $500.0 Maintain
28/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $485.0 Maintain
26/01/2018 Broker: Barclays Capital Rating: Hold New Target: $450.0
26/01/2018 Broker: Bank of America Rating: Buy New Target: $470.0
17/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $462.0 Maintain
11/01/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $465.0 Maintain
08/01/2018 Broker: Susquehanna Rating: Buy New Target: $511.0 Maintain
10/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $475.0 Maintain

FibroGen, Inc. (FGEN) formed multiple top with $56.23 target or 5.00% above today’s $53.55 share price. FibroGen, Inc. (FGEN) has $4.43B valuation. The stock decreased 3.16% or $1.75 during the last trading session, reaching $53.55. About 658,397 shares traded or 0.45% up from the average. FibroGen, Inc. (NASDAQ:FGEN) has risen 52.86% since March 7, 2017 and is uptrending. It has outperformed by 36.16% the S&P500.

Among 8 analysts covering FibroGen Inc (NASDAQ:FGEN), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. FibroGen Inc had 17 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, August 8 by Jefferies. The company was upgraded on Thursday, February 11 by Credit Suisse. The firm has “Hold” rating given on Wednesday, September 23 by Lake Street. The rating was initiated by Citigroup with “Buy” on Wednesday, July 29. Citigroup initiated FibroGen, Inc. (NASDAQ:FGEN) rating on Friday, December 4. Citigroup has “Buy” rating and $40 target. The stock has “Neutral” rating by Credit Suisse on Thursday, January 21. The stock of FibroGen, Inc. (NASDAQ:FGEN) has “Buy” rating given on Wednesday, February 28 by Leerink Swann. The company was downgraded on Friday, July 21 by Goldman Sachs. Mizuho initiated it with “Hold” rating and $61.0 target in Wednesday, October 4 report. As per Monday, August 14, the company rating was maintained by Jefferies.

Investors sentiment decreased to 1.15 in Q3 2017. Its down 0.06, from 1.21 in 2017Q2. It dropped, as 60 investors sold The Sherwin-Williams Company shares while 210 reduced holdings. 80 funds opened positions while 247 raised stakes. 69.43 million shares or 2.00% more from 68.06 million shares in 2017Q2 were reported. 14 are held by Stevens First Principles Advsr. Fred Alger Mgmt invested 0.68% in The Sherwin-Williams Company (NYSE:SHW). 1,176 were accumulated by Homrich And Berg. Peregrine Asset Advisers Inc holds 0.49% in The Sherwin-Williams Company (NYSE:SHW) or 2,600 shares. Great Lakes Advsrs Limited Co holds 3,104 shares. Fairfax Limited Can holds 683 shares. Moreover, Synovus Financial has 0.03% invested in The Sherwin-Williams Company (NYSE:SHW) for 4,410 shares. Moreover, Suntrust Banks has 0.04% invested in The Sherwin-Williams Company (NYSE:SHW). Kingdon Mngmt Ltd Liability reported 1.03% in The Sherwin-Williams Company (NYSE:SHW). Torray Lc accumulated 49,327 shares. 47,718 were accumulated by Eaton Vance Management. M&T National Bank Corporation reported 0.08% in The Sherwin-Williams Company (NYSE:SHW). Davis R M holds 0.6% or 40,324 shares in its portfolio. Meridian Mngmt accumulated 5,736 shares or 1.02% of the stock. Smith Moore And reported 0.06% of its portfolio in The Sherwin-Williams Company (NYSE:SHW).

The stock increased 2.02% or $7.93 during the last trading session, reaching $401.03. About 537,831 shares traded. The Sherwin-Williams Company (NYSE:SHW) has risen 15.27% since March 7, 2017 and is uptrending. It has underperformed by 1.43% the S&P500.

The Sherwin-Williams Company develops, makes, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail clients primarily in North and South America, the Caribbean, Europe, and Asia. The company has market cap of $37.50 billion. The firm operates in four divisions: Paint Stores Group, Consumer Group, Global Finishes Group, and Latin America Coatings Group. It has a 21.48 P/E ratio. It offers architectural paint and coatings, protective and marine products, automotive finishes and refinish products, original equipment maker product finishes, and related items under the Sherwin-Williams brand.